Hemophilia Federation of America (HFA) is pleased to announce that we will be hosting a 4-part Project ECHO® provider education series targeting obstetricians and gynecologists (OB/GYNs) with a focus on women and bleeding disorders. Project ECHO® uses a virtual telementor approach and believes in the “All Teach, All Learn” method. The series will occur on the 2nd Wednesday of each month at 11 AM EST, starting on August 10, 2022 and ending on November 9, 2022.

Women with bleeding and heavy menstrual bleeding are likely to consult their OB/GYN for help therefore, our target audience is OB/GYNs.  HFA believes that it is crucial that OB/GYNs are knowledgeable about bleeding disorders and identifying at-risk women and girls.  Our hope is that each session will foster discussion on key topics that speak to the unique current challenges that many OB/GYNs face daily.

Each session will have a didactic presentation followed by a case presentation where we hope to have active participation among the attendees. Each session will build on the previous lecture so we encourage you to attend all 4 sessions. The series was developed with subject matter experts and HFA looks forward to sharing this knowledge with you.

Physicians and nurses will receive 1 credit hour for their attendance at each session.

Topic: How do I screen for a bleeding disorder?

  • Date: Wednesday, August 10
  • Time: 11:00 am – 12:00 pm EST
  • Host/Moderator: Patricia Huguelet, MD
  • Presenter: Nancy Sokkary, MD
  • Target Audience: OB/GYN


Session One Objectives:

  • Recognize and identify the common signs and symptoms that raise the index of suspicion of an inherited bleeding disorder in women.
  • Share information with their patients regarding when bleeding may be considered abnormal and warrants further investigation.
  • Identify and locate resources and tools to screen for a bleeding disorder.

Didactic Presenter: Nancy Sokkary, MD

Nancy Sokkary, M.D., FACOG

Assistant Professor
Director, Pediatric & Adolescent Gynecology
Department of Obstetrics and Gynecology
Mercer University School of Medicine

Nancy Sokkary MD is a fellowship-trained Pediatric and Adolescent Gynecologist. She received her medical degree at the University of New Mexico School of Medicine and went on to complete an Obstetrics and Gynecology Residency at Kaiser East Bay, California and PAG fellowship at Baylor College of Medicine. She has since established Pediatric and Adolescent Gynecology Programs at two institutions and currently serves as the Director of Pediatric and Adolescent Gynecology at Emory University School of Medicine. Her clinical and research interests include adolescents with bleeding disorders, ovarian masses, and complex contraception. She served as the Chair for the North American Society for Pediatric and Adolescent Gynecology 2022 Annual Clinical and Research Meeting and continues to be a member of both the Education Committee and Anti-Racism Task Force. Dr. Sokkary is actively developing documents with the Foundation for Women and Girls with Blood Disorders regarding hormonal medication in the setting of blood disorders.


Time Presentation Presenters
11:00 – 11:02 AM EST Welcome, Introductions, and Housekeeping Patricia Huguelet, MD
11:02 – 11:22 AM EST How do I screen for a bleeding disorder? Nancy Sokkary, MD
11:22 – 11:27 AM EST Question and Answer Nancy Sokkary, MD
11:27 – 11:42 AM EST Case Presentation Nancy Sokkary, MD
11:42 – 11:47 AM EST Clarifying Questions Patricia Huguelet, MD
Nancy Sokkary, MD
11:47 – 11:57 AM EST Recommendations Nancy Sokkary, MD
11:57 – 11:59 AM EST Wrap-Up Patricia Huguelet, MD
11:59 – 12:00 PM EST Closing Remarks Patricia Huguelet, MD


PHI All patient information will be de-identified during the ECHO session.
Recording This session may be audio and video recorded. Your participation confirms your consent to this recording.
Continuing Medical Education (CME) Credit 1 Hour

This project is supported by cooperative agreement DD000008 from the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of an annual financial assistance award totaling $320,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

In support of improving patient care, this activity has been planned and implemented by the Hemophilia Federation of America and Project ECHO. Project ECHO is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Designation Statement

Project ECHO® designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC Designation Statement

Project ECHO® designates this live activity for a maximum of 1.0 ANCC contact hours. Nursing contact hours will be awarded for successful completion of program components based upon documented attendance and completion of evaluation.

Disclosure Statement

Project ECHO®, in compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, requires that anyone who is in a position to control the content of an educational activity disclose all relevant financial relationships they have had within the last 24 months with an ineligible company.

None of the planners and presenters for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.


  • Jacey Gonzalez, BA
  • Anne Goodman, MPH
  • G Shellye Horowitz, MA
  • Kristina Haley, DO, MCR
  • Lori Long, BS
  • Patricia Huguelet, MD
  • Whitney Armijo, BS
  • Janet Chupka, RN, BSN


  • Patricia Huguelet, MD
  • Nancy Sokkary, MD

The planners listed below have disclosed that they have a relevant financial relationship with an ineligible company.

Name Nature of Relationship Name of Ineligible Company
Skye Peltier, MPH, PA-C Advisor and Speaker Novo Nordisk
Skye Peltier, MPH, PA-C Advisor Sanofi
Stormy Johnson Independent Contractor and Speaker Medexus Pharmaceutical
Stormy Johnson Employee Paragon Healthcare
Kristina Haley, DO, MCR Principal Investigtor ATHN & HTRS

All of the relevant financial relationships listed for these individuals have been mitigated.

Please join us for our second Project ECHO series focusing on testing for bleeding disorders on September 14th at 11 am ET. Registration information to follow.

Sign up for E-mails, Dateline Magazine, and other ways to stay connected.